Assembly Biosciences (ASMB) Interest & Investment Income (2010 - 2026)
Assembly Biosciences' (ASMB) quarterly Interest & Investment Income came in at -$327000.0 in Q1 2026, down 678.57% year-on-year from $56518.5 in Q1 2025, and down 105.57% quarter-over-quarter from $5.9 million in Q4 2025.
Assembly Biosciences (ASMB) Interest & Investment Income (2010 - 2026) Analysis & Trends
Assembly Biosciences' Interest & Investment Income history runs 17 years deep, the most recent figure standing at -$327000.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 678.57% year-over-year to -$327000.0 in Q1 2026; TTM through Mar 2026 was $5.7 million, a 20.68% decrease from a year earlier, with the FY2025 full-year figure at $6.0 million, up 7.59% from the prior year.
- Interest & Investment Income retreated to -$327000.0 in Q1 2026 per ASMB's latest filing, from $5.9 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $5.9 million in Q4 2025 and bottomed at -$327000.0 in Q1 2026.
- The 5-year median for Interest & Investment Income is $189000.0 (2025), against an average of $1.1 million.
- Across the five-year window, Interest & Investment Income soared 62900.0% in 2023 and plunged 678.57% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $196000.0 in 2022, then jumped by 1391.33% to $2.9 million in 2023, then soared by 93.23% to $5.6 million in 2024, then advanced by 4.02% to $5.9 million in 2025, then slumped by 105.57% to -$327000.0 in 2026.
- Per Business Quant, the three latest ASMB Interest & Investment Income figures stand at -$327000.0 (Q1 2026), $5.9 million (Q4 2025), and $189000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Assembly Biosciences | 442.79 Mn | 216.19 Mn | - | -327,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -327,000.00 |
| Dec 31, 2025 | 5.88 Mn |
| Sep 30, 2025 | 189,000.00 |
| Jun 30, 2025 | -26,000.00 |
| Mar 31, 2025 | -42,000.00 |
| Dec 31, 2024 | 5.65 Mn |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 2.92 Mn |
| Sep 30, 2023 | 628,000.00 |
| Jun 30, 2023 | 188,000.00 |
| Mar 31, 2023 | 290,000.00 |
| Dec 31, 2022 | 196,000.00 |
| Sep 30, 2022 | -1,000.00 |
| Jun 30, 2022 | 112,000.00 |
| Mar 31, 2022 | 71,000.00 |
| Dec 31, 2021 | 101,000.00 |
| Sep 30, 2021 | -15,000.00 |
| Jun 30, 2021 | 71,000.00 |